Carlsmed director granted 13,698 RSUs in stock
CARLSMED, INC. director Philip M. Young received a grant of 13,698 restricted stock units (RSUs) of Common Stock on June 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
CARLSMED, INC. director Philip M. Young received a grant of 13,698 restricted stock units (RSUs) of Common Stock on June 3, 2026. Each RSU converts into one share when it vests.
The RSUs vest in full on the earlier of the day before Carlsmed’s 2027 annual stockholder meeting or June 3, 2027, as long as Young continues serving on the board through that date. Following this award, he holds 31,031 shares directly, 53,333 shares indirectly through PMY Partners L.P., where he is sole general partner with voting and dispositive power, and additional shares through the Young Family Trust, where he is a trustee with similar authority.
Insider Trade Summary
Grant/Award: 13,698 shares
Grant/Award
3 txns
Insider
YOUNG PHILIP M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 13,698 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 31,031 shares (Direct);
Common Stock — 88,899 shares (Indirect, See footnotes)
Footnotes (5)
- F1. Constitutes an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full on the earlier of (i) the day before the Issuer's 2027 annual meeting of stockholders or (ii) June 3, 2027, subject, in all cases, to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.
- F2. Stock held by PMY Partners LP.
- F3. Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.
- F4. Includes shares of the Issuer's common stock held by the Young Family Trust dtd 04/13/1998 Nancy Halsey Young & Philip Young, Trustees.
- F5. Reporting Person is a trustee of the Trust and has voting and dispositive power over the stock held by the Trust.
Key Figures
RSU grant size: 13,698 RSUs
Direct holdings after grant: 31,031 shares
PMY Partners L.P. holdings: 53,333 shares
+2 more
5 metrics
RSU grant size
13,698 RSUs
Award of restricted stock units on June 3, 2026
Direct holdings after grant
31,031 shares
Common Stock held directly following the RSU award
PMY Partners L.P. holdings
53,333 shares
Common Stock held indirectly via PMY Partners L.P.
Additional indirect trust holdings
35,566 shares
Common Stock held indirectly via Young Family Trust
RSU vesting date
Earlier of day before 2027 annual meeting or June 3, 2027
Single vesting date contingent on continued board service
Key Terms
restricted stock units ("RSUs"), voting and dispositive power, general partner, Trust
4 terms
restricted stock units ("RSUs") financial
"Constitutes an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
voting and dispositive power financial
"has voting and dispositive power over the stock held by PMY Partners L.P."
general partner financial
"Reporting Person is the sole general partner of PMY Partners L.P."
A general partner is the person or firm that runs an investment partnership and legally represents it — they make the day-to-day decisions, choose which assets to buy or sell, and are responsible for the partnership’s obligations. Investors care because the general partner’s judgment, risk-taking and fee and profit-sharing arrangements determine both the potential returns and the level of exposure to losses; think of the GP as the ship’s captain whose skill and honesty shape the voyage’s outcome.
Trust financial
"Includes shares of the Issuer's common stock held by the Young Family Trust dtd 04/13/1998"
A trust is a legal setup in which one party (the trustee) holds and manages assets—like cash, stocks or property—on behalf of other people (beneficiaries) according to instructions from the person who created it (the grantor). Think of it as a locked box with a keyholder who must follow written rules; for investors it matters because trusts influence who controls and benefits from assets, affect taxes and succession, and can change how quickly or transparently shares are bought, sold or voted.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Carlsmed (CARL) director Philip M. Young receive in this Form 4?
Philip M. Young received a grant of 13,698 restricted stock units (RSUs) of Carlsmed Common Stock. Each RSU represents the right to receive one share upon vesting, providing equity-based compensation tied to his continued board service.
When do Philip M. Young’s 13,698 RSUs in Carlsmed (CARL) vest?
The 13,698 RSUs vest in full on the earlier of the day before Carlsmed’s 2027 annual stockholder meeting or June 3, 2027. Vesting is contingent on Young’s continued service on the Board of Directors through that date.
What indirect Carlsmed (CARL) holdings are associated with Philip M. Young?
Indirect holdings include shares held by PMY Partners L.P. and by the Young Family Trust dated April 13, 1998. Young is sole general partner of PMY Partners and a trustee of the trust, giving him voting and dispositive power over those shares.
Is the RSU grant to Carlsmed (CARL) director Philip M. Young an open-market purchase?
No, the 13,698-share RSU grant is a compensation-related award, not an open-market purchase. It was reported with transaction code A, indicating a grant, award, or other acquisition rather than a market buy or sell transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates